QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
NYSE:AMAM

Ambrx Biopharma - AMAM News Today

$1.79
-0.01 (-0.56%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.75
$1.83
50-Day Range
$0.41
$4.54
52-Week Range
$0.38
$5.12
Volume
117,880 shs
Average Volume
678,749 shs
Market Capitalization
$69.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Get Ambrx Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMAM and its competitors with MarketBeat's FREE daily newsletter.


AMAM Media Mentions By Week

AMAM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AMAM
News Sentiment

1.29

0.46

Average
Medical
News Sentiment

AMAM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AMAM Articles
This Week

1

1

AMAM Articles
Average Week

SourceHeadline
finance.yahoo.com logoAmbrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph.D. as Head of Clinical Development
finance.yahoo.com - February 3 at 8:20 AM
seekingalpha.com logoAmbrx Biopharma: Some Promise, Much Uncertainty
seekingalpha.com - January 18 at 9:21 PM
finance.yahoo.com logoThe past year for Ambrx Biopharma (NYSE:AMAM) investors has not been profitable
finance.yahoo.com - January 16 at 9:58 AM
msn.com logoAmbrx Biopharma receives NYSE notice for non-compliance
msn.com - December 19 at 10:11 AM
finance.yahoo.com logoAmbrx Biopharma Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
finance.yahoo.com - December 16 at 6:08 PM
markets.businessinsider.com logoCowen & Co. Keeps Their Buy Rating on Ambrx Biopharma (AMAM)
markets.businessinsider.com - December 11 at 7:42 PM
finance.yahoo.com logoMeet the Biotech Stock That Jumped Over 1000% in One Day
finance.yahoo.com - December 11 at 2:42 PM
benzinga.com logoThinking about buying stock in Ambrx Biopharma, Plug Power, Hello Group, Credit Suisse, or Carvana?
benzinga.com - December 9 at 3:37 PM
seekingalpha.com logoAmbrx stock surges 160% as drug shows promise in phase 2 breast cancer trial
seekingalpha.com - December 9 at 3:37 PM
finance.yahoo.com logoAmbrx Shares Surge After Encouraging Early Safety, Efficacy Data From Breast Cancer Candidate
finance.yahoo.com - December 9 at 3:37 PM
finance.yahoo.com logoAmbrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment
finance.yahoo.com - December 9 at 9:05 AM
finance.yahoo.com logoCan Ambrx Biopharma (NYSE:AMAM) Afford To Invest In Growth?
finance.yahoo.com - December 6 at 1:48 PM
finance.yahoo.com logoInterim Data from Ambrx’s Study of ARX788 selected for Spotlight Poster Discussion at the 2022 San Antonio Breast Cancer Symposium
finance.yahoo.com - November 29 at 9:57 AM
seekingalpha.com logoWeek In Review: Insilico Signs Six-Drug AI Discovery Deal With Sanofi Worth Up To $1.2 Billion
seekingalpha.com - November 14 at 6:08 AM
finance.yahoo.com logoAmbrx Announces NovoCodex’s Dosing of First Patient with ARX305, Ambrx’s Investigational Antibody Drug Conjugate Targeting CD70
finance.yahoo.com - November 9 at 10:39 AM
finance.yahoo.com logoAmbrx Biopharma Inc. Appoints Daniel O’Connor as Chief Executive Officer
finance.yahoo.com - November 1 at 10:38 PM
finance.yahoo.com logoAmbrx Biopharma Stops Working On Breast Cancer Candidate, Cites Competition As The Reason
finance.yahoo.com - October 19 at 7:03 PM
finance.yahoo.com logoAmbrx Biopharma Inc. Announces Strategic Reprioritization and Provides Corporate Update
finance.yahoo.com - October 18 at 4:56 PM
finance.yahoo.com logoAmbrx Biopharma to Host Corporate Update Conference Call
finance.yahoo.com - October 11 at 6:28 PM
finance.yahoo.com logoAmbrx Biopharma Inc. Reports 1H 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - August 29 at 8:15 PM
wsj.com logoAmbrx Biopharma Inc. ADR
wsj.com - August 19 at 8:06 PM
marketwatch.com logoAmbrx Biopharma Names Kate Hermans Interim Chief Executive Officer
marketwatch.com - August 16 at 4:48 PM
finance.yahoo.com logoAmbrx Biopharma Appoints Kate Hermans as Interim CEO, Replacing Feng Tian
finance.yahoo.com - August 16 at 4:48 PM
finance.yahoo.com logoAmbrx Biopharma Appoints Edward Hu and Kate Hermans to its Board of Directors
finance.yahoo.com - July 5 at 4:14 PM
finance.yahoo.com logoAmbrx Biopharma Inc. to Present at the H.C. Wainwright Preclinical Cancer Drug Discover Conference
finance.yahoo.com - June 28 at 6:50 PM
finance.yahoo.com logoInvestors are selling off Ambrx Biopharma (NYSE:AMAM), lack of profits no doubt contribute to shareholders one-year loss
finance.yahoo.com - June 20 at 10:49 AM
finance.yahoo.com logoAmbrx Biopharma Inc. Appoints Janet Loesberg to Board of Directors
finance.yahoo.com - June 6 at 11:16 AM
benzinga.com logoAmbrx Biopharma (NYSE:AMAM), Analyst Ratings, Price Targets, Predictions
benzinga.com - May 30 at 11:19 AM
seekingalpha.com logoAmbrx Biopharma appoints chief medical officer
seekingalpha.com - May 19 at 8:22 PM
finance.yahoo.com logoAmbrx Biopharma Inc. Appoints Janice Lu, M.D., Ph.D., as Chief Medical Officer
finance.yahoo.com - May 17 at 5:10 PM
finance.yahoo.com logoAmbrx Biopharma Inc. to Present at Upcoming Investor Conferences
finance.yahoo.com - May 6 at 5:35 PM
finance.yahoo.com logoWhat Kind Of Shareholders Own Ambrx Biopharma Inc. (NYSE:AMAM)?
finance.yahoo.com - May 6 at 7:33 AM
nasdaq.com logoAMAM Awaits ACE-Breast-02 Study Data, CNC Posts Strong Q1 Results, EXAS Boosts Outlook
nasdaq.com - April 27 at 3:25 AM
seekingalpha.com logoAmbrx Biopharma Inc. (AMAM) CEO Feng Tian on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com - April 26 at 10:20 PM
finance.yahoo.com logoAmbrx Biopharma Inc. Reports Full Year 2021 Financial Results; Provides Corporate Update
finance.yahoo.com - April 26 at 5:14 PM
finance.yahoo.com logoAmbrx Biopharma Inc. and Quantum Leap Healthcare Collaborative™ Announce the Inclusion of ARX788 in the I-SPY 2.2 Phase 2 Adaptive Clinical Trial for Breast Cancer
finance.yahoo.com - April 26 at 2:13 AM
finance.yahoo.com logoAmbrx Biopharma Inc. to Release Full Year 2021 Financial Results on Tuesday, April 26, 2022
finance.yahoo.com - April 21 at 7:32 PM
finance.yahoo.com logoAmbrx Biopharma Inc. Sponsored ADR (AMAM) Could Find Support Soon, Here's Why You Should Buy the Stock Now
finance.yahoo.com - April 14 at 3:58 PM
benzinga.com logoBaird Initiates Coverage On Ambrx Biopharma with Outperform Rating, Announces Price Target of $16
benzinga.com - April 7 at 9:13 AM
finance.yahoo.com logoAmbrx Biopharma Inc. to Present at Oppenheimer’s 32nd Annual Healthcare Conference
finance.yahoo.com - March 8 at 10:31 AM
finance.yahoo.com logoAmbrx Biopharma Inc. to Participate in the Cowen 42nd Annual Health Care Conference
finance.yahoo.com - February 28 at 9:58 PM
benzinga.com logoGoldman Sachs Initiates Coverage On Ambrx Biopharma with Neutral Rating, Announces Price Target of $6
benzinga.com - February 28 at 10:41 AM
uk.investing.com logoAmbrx Biopharma Inc ADR (AMAM)
uk.investing.com - February 26 at 8:26 PM
finance.yahoo.com logoAmbrx Biopharma Inc. Announces Submission of IND Application for ARX305 with the U.S. FDA
finance.yahoo.com - February 15 at 11:18 AM
finance.yahoo.com logoAmbrx Biopharma Inc. Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee
finance.yahoo.com - February 7 at 12:07 PM
nasdaq.com logoAmbrx Biopharma Inc. American Depositary Shares (each representing seven Ordinary Shares) (AMAM)
nasdaq.com - January 28 at 11:58 PM
nasdaq.com logoAmbrx Biopharma Inc - ADR Shares Near 52-Week Low - Market Mover
nasdaq.com - January 14 at 6:34 PM
nasdaq.com logoAmbrx Biopharma Inc - ADR Shares Fall 0.3% Below Previous 52-Week Low - Market Mover
nasdaq.com - January 13 at 9:46 PM
nasdaq.com logoAmbrx Biopharma Inc - ADR Shares Close the Day 10.7% Lower - Daily Wrap
nasdaq.com - January 13 at 9:46 PM
nasdaq.com logoAmbrx Biopharma Inc - ADR Shares Fall 2.8% Below Previous 52-Week Low - Market Mover
nasdaq.com - January 13 at 12:53 AM
Get Ambrx Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMAM and its competitors with MarketBeat's FREE daily newsletter.

This page (NYSE:AMAM) was last updated on 2/6/2023 by MarketBeat.com Staff